Julie Lasvergnas

Adoptive cell therapies in thoracic malignancies

L. Zelek, N. Chaput, K. Chouahnia, 2022, Cancer Immunology, Immunotherapy.

PDL1-status predicts primary resistance of metastatic, EGFR-mutated non small cell lung cancers to EGFR tyrosine-kinase inhibitors.

B. Duchemann, J. Cadranel, S. Jouveshomme, 2023, Respiratory medicine and research.